1. Home
  2. INTA vs CYTK Comparison

INTA vs CYTK Comparison

Compare INTA & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTA
  • CYTK
  • Stock Information
  • Founded
  • INTA 2000
  • CYTK 1997
  • Country
  • INTA United States
  • CYTK United States
  • Employees
  • INTA N/A
  • CYTK N/A
  • Industry
  • INTA Computer Software: Prepackaged Software
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • INTA Technology
  • CYTK Health Care
  • Exchange
  • INTA Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • INTA 5.6B
  • CYTK 5.6B
  • IPO Year
  • INTA 2021
  • CYTK 2004
  • Fundamental
  • Price
  • INTA $58.40
  • CYTK $40.19
  • Analyst Decision
  • INTA Buy
  • CYTK Strong Buy
  • Analyst Count
  • INTA 12
  • CYTK 17
  • Target Price
  • INTA $67.90
  • CYTK $82.00
  • AVG Volume (30 Days)
  • INTA 516.5K
  • CYTK 1.6M
  • Earning Date
  • INTA 05-06-2025
  • CYTK 05-07-2025
  • Dividend Yield
  • INTA N/A
  • CYTK N/A
  • EPS Growth
  • INTA N/A
  • CYTK N/A
  • EPS
  • INTA N/A
  • CYTK N/A
  • Revenue
  • INTA $465,029,000.00
  • CYTK $18,474,000.00
  • Revenue This Year
  • INTA $18.66
  • CYTK $55.82
  • Revenue Next Year
  • INTA $15.00
  • CYTK $683.10
  • P/E Ratio
  • INTA N/A
  • CYTK N/A
  • Revenue Growth
  • INTA 18.58
  • CYTK 145.34
  • 52 Week Low
  • INTA $30.36
  • CYTK $39.81
  • 52 Week High
  • INTA $77.74
  • CYTK $75.71
  • Technical
  • Relative Strength Index (RSI)
  • INTA 40.00
  • CYTK 35.75
  • Support Level
  • INTA $58.74
  • CYTK $42.66
  • Resistance Level
  • INTA $64.31
  • CYTK $48.43
  • Average True Range (ATR)
  • INTA 2.13
  • CYTK 2.04
  • MACD
  • INTA 0.22
  • CYTK -0.21
  • Stochastic Oscillator
  • INTA 21.08
  • CYTK 4.41

About INTA Intapp Inc.

Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital, investment banking, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: